Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/10442/19387
Εξειδίκευση τύπου : | Άρθρο σε επιστημονικό περιοδικό |
Τίτλος: | The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma |
Δημιουργός/Συγγραφέας: | Malamos, Panagiotis Papanikolaou, Christina Gavriatopoulou, Maria Dimopoulos, Meletios A Terpos, Evangelos [EL] Σουλιώτης, Βασίλης Λ.[EN] Souliotis, Vassilis L. |
Ημερομηνία: | 2024-06-26 |
Γλώσσα: | Αγγλικά |
ISSN: | 1422-0067 |
DOI: | 10.3390/ijms25136991 |
Άλλο: | 39000097 |
Περίληψη: | The DNA damage response (DDR) network and the mitogen-activated protein kinase (MAPK) signaling pathway are crucial mechanisms for the survival of all living beings. An accumulating body of evidence suggests that there is crosstalk between these two systems, thus favoring the appropriate functioning of multi-cellular organisms. On the other hand, aberrations within these mechanisms are thought to play a vital role in the onset and progression of several diseases, including cancer, as well as in the emergence of drug resistance. Here, we provide an overview of the current knowledge regarding alterations in the DDR machinery and the MAPK signaling pathway as well as abnormalities in the DDR/MAPK functional crosstalk in multiple myeloma, the second most common hematologic malignancy. We also present the latest advances in the development of anti-myeloma drugs targeting crucial DDR- and MAPK-associated molecular components. These data could potentially be exploited to discover new therapeutic targets and effective biomarkers as well as for the design of novel clinical trials. Interestingly, they might provide a new approach to increase the efficacy of anti-myeloma therapy by combining drugs targeting the DDR network and the MAPK signaling pathway. |
Τίτλος πηγής δημοσίευσης: | International journal of molecular sciences |
Τόμος/Κεφάλαιο: | 25 |
Τεύχος: | 13 |
Θεματική Κατηγορία: | [EL] Μοριακή Βιολογία[EN] Molecular Biology [EL] Κυτταρολογία[EN] Cytology [EL] Γενετική[EN] Genetics [EL] Θεραπευτική. Φαρμακολογία[EN] Therapeutics.Pharmacology [EL] Νεοπλάσματα. Όγκοι. Ογκολογία (περ. Καρκίνος, κακινογόνες ουσίες)[EN] Neoplasms. Tumors. Oncology (Incl.cancer, carcinogens) |
Λέξεις-Κλειδιά: | DDR/MAPK interplay DNA damage response (DDR) combination therapy mitogen-activated protein kinase (MAPK) multiple myeloma (MM) |
Χρηματοδότης: | European Union |
EU Grant identifier: | 101097094-ELMUMY |
Κάτοχος πνευματικών δικαιωμάτων: | © 2024 by the authors. Licensee MDPI, Basel, Switzerland. |
Όροι και προϋποθέσεις δικαιωμάτων: | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). |
Ηλεκτρονική διεύθυνση στον εκδότη (link): | https://doi.org/10.3390/ijms25136991 |
Εμφανίζεται στις συλλογές: | Ινστιτούτο Χημικής Βιολογίας - Επιστημονικό έργο
|